glp-1 and nad Unlocking Synergy: How NAD+ Injections Enhance the Effects of Weight Loss Medications GLP-1 and NAD+ - Precision

GLP-1 Receptor Agonists - Podcast Version GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medicines used for the treatment of type 2 diabetes and, more recently, for weight management

Wegovy is titrated up to a higher maintenance dose of 2.4 mg of semaglutide weekly, which is optimized for weight loss

Electrolyte composition and concentration should be appropriate for maintenance rather than extreme athletic performance

Peak asks the FDA black-box family-history screen (thyroid cancer + MEN-2), the eating-disorder disqualifier (anorexia/bulimia), a pancreatitis/T1D knockout list, a comorbidity multi-select, a dedicated diabetes-drug interaction check, and bariatric surgery history